Washington, DC 20006-5349
HELPLINE
At the Mesothelioma Applied Research Foundation, we are guided by the three core pillars that define our purpose: funding groundbreaking research, providing essential treatment support…
The phase 3 clinical trial known as BEAT-meso, which combines chemotherapy plus bevacizumab with immunotherapy, has shown an improvement in overall survival (OS) and progression-free…
One of the many services that the Meso Foundation offers to patients, caregivers, and the bereaved community is support groups offered over Zoom video conferencing.…
In this episode of MesoTV, three patients, two with peritoneal mesothelioma and one with pleural mesothelioma, tell their stories of diagnosis, treatment, subsequent recurrence, and…
A study just published by researchers at Fox Chase Cancer Center revealed that even low exposures to any type of asbestos, including chrysotile, can increase…
The Meso Foundation’s International Symposium on Malignant Mesothelioma is a unique conference that brings together the entire mesothelioma community. We invite patients, their families, caregivers,…
The field of integrative medicine combines conventional therapies with complementary ones in a thoughtful way to optimize outcomes and/or quality of life. Services provided under…
The Mesothelioma Applied Research Foundation is hiring! EXECUTIVE DIRECTOR Background The Mesothelioma Applied Research Foundation (Meso Foundation) is the nonprofit collaboration of patients and families,…
This episode of MesoTV features Jacob Strand, MD in an interview with Mesothelioma Applied Research Foundation’s nurse, Julie White, RN, BSN, OCN. The topic of…
The U.S. Environmental Protection Agency (EPA) announced today that the first rule to be finalized under the Toxic Substance Control Act is a ban on…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
